This trial has ended
Research Title: Study of Comparative Treatments for Retinal Vein Occlusion 2 [SCORE2]: a Multicenter, Prospective, Randomized Non-inferiority Trial of Eyes With Macular Edema Secondary to Central Retinal Vein Occlusion, Comparing Intravitreal Bevacizumab Every 4 Weeks With Intravitreal Aflibercept Every 4 Weeks.
Sponsor: The EMMES Corporation
Principal Investigator: Robert A Stoltz, M.D., Ph.D.
Description: SCORE2 is a multicenter, prospective, randomized, phase III clinical trial in which all participants enrolled will be followed for 12 months. SCORE2 is designed as a non-inferiority trila, with study eyes randomized to intravitreal bevacizumab (1.25 mg) every 4 weeks vs. intravitreal aflibercept (2.0 mg) every 4 weeks. SCORE2 aims to determine if bevacizumab is non-inferior to aflibercept for the treatment of macular edema associated with central retinal vein occlusion (CRVO), with the primary outcome of visual acuity measured at Month 6.
Start Date: September 2014
Recruitment: Complete
Project Personnel: Leslie Marcus, CCRC
Location(s): Marietta; 833 Campbell Hill Street, Suite 300, Marietta, GA 30060
Clinical Trial Team
Active Trials
Past Trials
- AART C-02-60
 - Acucela 4429-202 SEATTLE
 - Aerpio AKB-9778-CI-5001 TIME-2b
 - Allergan 150998-005 CEDAR
 - Allergan 1771-201-008 MAPLE
 - Allergan 190342-038 BEACON
 - ALLERGAN 206207-012
 - AREDS2
 - AREDS2 ForeseeHome
 - Blair Symington
 - C-09-067 RACE
 - DRCR.net Protocol N
 - Gemini GEM-NH-002 Clarity 2
 - Genentech GR39821
 - Graybug GBV-102-002 Altissimo
 - HORIZON FVF3426g
 - KalVista KVD011-201
 - LFG316A2203
 - MARINA FVF2598g
 - Novartis CSPP100A2244
 - Ocriplasmin Research to Better Inform Treatment (ORBIT)
 - OPH1002
 - OPH1004
 - Ophthotech OPH2003
 - PDEX
 - Regeneron R2176-3-AMD-1417 CAPELLA
 - Regeneron R910-3-AMD-1517 ONYX
 - Regeneron R910-3-DME-1518 RUBY
 - Regeneron VGFTe-OD-1411 PANORAMA
 - RIDE FVF4168g
 - RISE FVF4170g
 - Roche BP 30099 BOULEVARD
 - Roche BP29647 AVENUE
 - Roche GX29176 CHROMA
 - Roche GX30191 OMASPECT
 - SAILOR FVF3689g
 - SCORE
 - SCORE2
 - Shelby Satterwhite
 - Suprachoroidal Buckling for Retinal Detachment
 - Taiwan Liposome Company (TLC) TLC399A2002
 - Xcenda C-01-17 ForeseeHome